GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Other Long Term Assets

Laurus Labs (BOM:540222) Other Long Term Assets : ₹4,217 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Other Long Term Assets?

Laurus Labs's other long-term assets for the quarter that ended in Mar. 2025 was ₹4,217 Mil.

Laurus Labs's quarterly other long-term assets declined from Sep. 2024 (₹2,523 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹4,217 Mil).

Laurus Labs's annual other long-term assets declined from Mar. 2023 (₹2,393 Mil) to Mar. 2024 (₹2,392 Mil) but then increased from Mar. 2024 (₹2,392 Mil) to Mar. 2025 (₹4,217 Mil).

Laurus Labs Other Long Term Assets Historical Data

The historical data trend for Laurus Labs's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Other Long Term Assets Chart

Laurus Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,430.40 1,577.40 2,393.20 2,392.10 4,216.70

Laurus Labs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,392.10 - 2,522.50 - 4,216.70

Laurus Labs Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Laurus Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Other Long Term Assets
Comparable Companies
BOM:532331 BOM:543635 BOM:524494 BOM:506943 NSE:GLAND BOM:544210 BOM:532296 BOM:543064 BOM:532300 BOM:540596 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
LAURUSLABS:India
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Website
https://www.lauruslabs.com
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs Headlines

No Headlines